Cell line · CVCL_0223
Papers26
1 to 20 of 26
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| In Situ Genetic Engineering Facilitates MMP-9-Responsive TIMP1 Release Through Proteolytic Cleavage to Boost Diabetic Wound Healing. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Calcium and Cadmium Activate ESRRB to Mediate Cell Stemness and Pluripotency. | Int J Mol Sci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Coral anthozoan-specific opsins employ a novel chloride counterion for spectral tuning. | Elife | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation. | J Med Chem | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Androgen receptor-mediated assisted loading of the glucocorticoid receptor modulates transcriptional responses in prostate cancer cells. | Genome Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells. | Cells | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Investigation of Fibrillar Aggregates Formed by Pathogenic Pre-pro-vasopressin Mutants that Cause ADNDI. | J Clin Endocrinol Metab | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Uncovering the BIN1-SH3 interactome underpinning centronuclear myopathy. | Elife | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Transduction Efficiency of Zika Virus E Protein Pseudotyped HIV-1gfp and Its Oncolytic Activity Tested in Primary Glioblastoma Cell Cultures. | Cancers (Basel) | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells. | Int J Mol Sci | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950. | Cancer Res Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. | Cell | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Differential off-target glucocorticoid activity of progestins used in endocrine therapy. | Steroids | 2022 | Its Methods give the RRID and name the line | PubMed | |
| High-throughput sequencing for species authentication and contamination detection of 63 cell lines. | Sci Rep | 2021 | Cellosaurus cites it | PubMed | |
| Clinical and Functional Consequences of C-Terminal Variants in MCT8: A Case Series. | J Clin Endocrinol Metab | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Insights Into the Mechanism of MCT8 Oligomerization. | J Endocr Soc | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Agonist-specific voltage-dependent gating of lysosomal two-pore Na+ channels. | Elife | 2019 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0223/papers